Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
February 1999

Serial Brain SPECT Images in a Case of Sydenham Chorea

Author Affiliations

From the Department of Neurology (Drs P. H. Lee, Nam, K. Lee, and B. I. Lee) and the Division of Nuclear Medicine, Department of Diagnostic Radiology (Dr J. D. Lee), Yonsei University College of Medicine, Seoul, Korea.


Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999

Arch Neurol. 1999;56(2):237-240. doi:10.1001/archneur.56.2.237

Background  The pathophysiological nature of Sydenham chorea (SC) has been presumed to be an autoimmune-mediated inflammatory process. Positron emission tomography in SC has revealed a striatal hypermetabolism that might explain the transient neuronal dysfunction. However, any focal hyperperfusion in the striatum or its related structures has not been demonstrated in previous single photon emission computed tomographic (SPECT) imaging studies, which raised a concern about the pathogenesis of the striatal hypermetabolism.

Objective  To investigate the cerebral perfusion patterns of the subcortical structures by using serial technetium Tc 99m–ethyl cysteinate dimer SPECT in a case of SC, which may provide a clue for the pathophysiological mechanisms.

Design  A case report and serial SPECT studies.

Case Presentation  A girl aged 4 years 3 months showed severe generalized choreic movements with concomitant signs of acute pharyngitis. Results of a laboratory study taken 7 days after the onset of chorea showed elevated antistreptolysin O titer, C-reactive protein levels, and erythrocyte sedimentation rate. Other laboratory data, throat culture, echocardiography, brain magnetic resonance imaging, and electroencephalography did not reveal any abnormalities. Five days after treatment with haloperidol and penicillin, the chorea began to improve slowly, and completely resolved in 2 months.

Results  Three serial SPECT images and semiquantitative analysis of cerebral perfusion were obtained. Cerebral perfusion in the striatum and thalamus was markedly increased bilaterally during the stage of active chorea and then returned nearly to its baseline level during the convalescent phase. These cerebral perfusion patterns were concordant with semiquantitative analysis.

Conclusions  Hyperperfusion in both the striatum and thalamus in our patient may reflect the subcortical inflammatory processes in SC. The unequivocal SPECT findings in our patient are difficult to reconcile with the negative findings of previous SPECT studies but may suggest the heterogeneity of the perfusion patterns in SC.

SYDENHAM CHOREA (SC) is a movement disorder of childhood usually associated with β-hemolytic streptococcal infection. The pathophysiology of SC is still unclear; however, the cross-reactivity of a streptococcal antibody with basal ganglionic neurons1 and the demonstration of brain cross-reactive epitopes of streptococcal M protein2 caused an autoimmune-mediated inflammatory process. Recent investigations using positron emission tomography (PET) or single photon emission computed tomography (SPECT) revealed variable imaging features in a few cases of SC. Positron emission tomographic studies3,4 showed isolated striatal glucose hypermetabolism, which suggested that SC was a striatal disease. However, it is still unknown whether the striatal hypermetabolism reflects the striatal neuronal dysfunction related to the focal inflammatory process or the enhanced neuronal activities resulting from the enhanced glutamatergic corticostriatal inputs. In SPECT studies, Hill et al5 did not find any perfusion abnormalities in a case of SC, but Heye et al6 reported a hypoperfusion in the basal ganglia in another case. These SPECT features were somewhat difficult to reconcile with the PET results. We conducted a serial SPECT imaging study using technetium Tc 99m– ethyl cysteinate dimer (99mTc-ECD) in a patient with SC.


A girl aged 4 years 3 months without any history of antenatal or perinatal illnesses was referred to our neurology department for evaluation of continuous involuntary movements of 6 days' duration. There was no family history of such disorders. Her motor development had been delayed; she sat up at age 15 months, crawled at age 20 months, and stood at age 24 months. Seven months prior to our evaluation, a transient episode of abnormal involuntary movements developed in association with an acute pharyngitis and fever. The episode lasted for 2 days and then disappeared. The description of the movements in that episode was similar to those of this most recent event.

Three months prior to our seeing her, the patient had been admitted to the rehabilitation center for evaluation of delayed development. Examination revealed a moderate spastic diplegia with increased tendon reflexes, extensor plantar reflexes, and delayed developmental milestones. Motor and psychomotor development index values were both lower than 50 on the Bayley scales (motor normal, ≥102; psychomotor normal, ≥158). Results of brain magnetic resonance imaging and laboratory studies, including a chromosomal study and amino acid analysis, were normal. She was diagnosed as having cerebral palsy and enrolled in the rehabilitation program for treatment of the spastic diplegia. During the course of the rehabilitation program, she developed an acute pharyngitis with fever and swollen and infected tonsils. The involuntary movements developed shortly thereafter and gradually worsened. Her condition was treated with antibiotics and intermittent administration of sedative drugs for 6 days before her referral to us.

At the time of examination, her body temperature was 38.5°C and her tonsils were swollen and infected. A mild, diffuse hypotonia was noted with extensor plantar reflexes; deep tendon reflexes were mildly decreased. The involuntary movements consisted of irregular, unpredictable, flowing, and large-amplitude activities that involved all 4 extremities as well as the face. The clinical feature of involuntary movements was consistent with chorea intermixed with athetoid components. The chorea persisted only during waking periods and spontaneously disappeared during sleep.

Results of laboratory studies taken 7 days after the onset of chorea revealed that antistreptolysin O titer was 217 IU/mL (normal, < 200 IU/mL), C-reactive protein was 1.25 mg/dL (normal, < 0.8 mg/dL), and the erythrocyte sedimentation rate was 50 mm/h. The results of other routine blood chemistry, antiphospholipid antibody, lupus anticoagulant antibody, serum copper, and ceruloplasmin tests, as well as tests for thyroid function, rheumatic factor, antinuclear antibody, and mycoplasma antibody were all normal. Throat culture and peripheral blood smear were negative for organisms, and her echocardiogram showed no abnormalities. Results of brain magnetic resonance imaging and electroencephalography were normal. Diagnosis of SC was made, and treatment with haloperidol and penicillin was started on the ninth day. Five days after the start of treatment with medication, the chorea gradually began to diminish and completely disappeared in 2 months.


After sedation with intravenous injection of lorazepam, 99mTc-ECD was given intravenously and SPECT images were obtained with a brain-dedicated annular crystal gamma camera equipped with low-energy, high-resolution, parallel-hole collimators (Digital Scintigraphics Inc, Waltham, Mass). We acquired 120 projections using a 128 × 128 matrix for 20 minutes. Scatter correction and backprojection with a Butterworth filter (cutoff frequency 1.1 cycle/min, order No. 10) were performed. Attenuation correction of transaxial images (slice thickness = 1.67 mm) was performed by Chang's7 method, and coronal and sagittal slices were calculated with the original transaxial images.

The first SPECT was undertaken 3 months previously as a baseline workup for the rehabilitation therapy of cerebral palsy, when the patient was free of any involuntary movements. It revealed slightly decreased cerebral perfusion in the left striatum and thalamus ( Figure 1, SPECT 1). The second SPECT was undertaken on the 11th day of chorea when active choreic movements were continuing. At that time, 99mTc-ECD was injected while she was on the ward at the rehabilitation facility 10 minutes after the complete disappearance of chorea, which resulted from the intravenous injection of lorazepam used to put her to sleep. The second SPECT image showed a marked hyperfixation of radioligand in both striatum and thalamus bilaterally compared with SPECT 1 ( Figure 1, SPECT 2). Two months later, the third SPECT image was taken when the chorea had disappeared completely, which revealed the return of striatothalamic hyperperfusion to the baseline level ( Figure 1, SPECT 3).

Image not available

The first single photon emission computed tomographic image, SPECT 1, taken when the patient was free of any involuntary movements, reveals mildly decreased cerebral perfusion in the left striatum and thalamus. The second image, SPECT 2, was taken 3 months later during active chorea, and shows marked hyperperfusion in both the left striatum and thalamus. The third image, SPECT 3, taken during the convalescent phase, shows the return to nearly baseline level of the hyperperfused area observed in the SPECT 2.

We also conducted a semiquantitative analysis. In consideration of normal cerebellar perfusion in baseline SPECT and of the structure least relevant to chorea, we chose a cerebellar activity as the reference for the calculation of the relative perfusion ratio. A region of interest was manually drawn over the cerebellum and mean pixel counts were obtained. The region of interest was drawn over the right striatum and thalamus of SPECT 2 with the same region of interest mirrored to the contralateral side and in the same area of SPECT 1 and SPECT 3. The lesion-cerebellar ratio of each SPECT image was calculated, and the changes in perfusion relative to the SPECT 1 scan were obtained (Table 1). Semiquantitative analysis revealed a definite perfusion increase in the bilateral striatum and thalamus by 18% to 21% in the SPECT 2 image with only minimal perfusion changes between the SPECT 1 and SPECT 3 images.

Image not available
Mean Pixel Count Ratio Seen in the SPECT Images— ROI: Whole Cerebellum—and Perfusion Differences From SPECT 1 ROI Revealed in Subsequent Images*

The serial SPECT images and semiquantitative analysis in our case clearly demonstrated a reversible focal hyperperfusion in the striatum and thalamus bilaterally during the active phase of SC, which suggested that increased cerebral blood flow (CBF) of the whole thalamostriatal circuitry was responsible for the genesis of chorea. However, our results were quite different from the previous reports of SPECT and PET in SC, which showed either no abnormalities or hypoperfusion in the striatum in SPECT5,6 and an isolated striatal hypermetabolism with normal thalamic metabolism in PET.3,4 These discrepancies between our results and others are quite difficult to explain. In fact, our patient had cerebral palsy, and the baseline SPECT study (Figure 1, SPECT 1) revealed left striatothalamic hypoperfusion, which might be responsible for the different cerebral perfusion pattern observed in the previous cases. Cerebral palsy is associated with diverse perfusion patterns in SPECT, and the SPECT features in our patient were not unusual in cerebral palsy in our experience.8 However, cerebral palsy is a static process and may not have any interactions with the pathogenesis of SC. In addition, the SPECT 3 scan revealed a perfusion pattern similar to that seen in SPECT 1, which had confirmed that the chorea was reversible and independent of the underlying cerebral palsy.

We used 99mTc-ECD as radioligand for CBF, but others used technetium Tc 99m–hexylmethylpropylene amineoxine. All these radioligands have been recognized as reliable CBF agents, and the use of different radioligands is quite unlikely to be responsible for the different results. However, a comparative trial of different radioligands in SC may be required to resolve this issue.

The other possibility would be the movement-related hyperperfusion in the thalamostriatum. However, the voluntary movement-related hyperperfusion usually involves both striatum and motor cortex to the same degree.9 In addition, we intentionally avoided such choreic movements by putting the patient to sleep using intravenous lorazepam before the injection of radioligand for the second SPECT study. We were not able to find any technical errors involved with the SPECT studies in this patient.

The striatal hyperperfusion in our patient agrees well with the isolated striatal hypermetabolism noted in previous PET studies in cases of SC.3,4 Striatal hypermetabolism and hyperperfusion clearly suggest the presence of striatal neuronal dysfunction related to either the direct consequence of underlying pathogenesis of SC, a probable autoimmune-mediated inflammatory process, or secondarily enhanced striatal neuronal activities due to increased corticostriatal synaptic activities. However, the thalamic hyperperfusion in our patient was difficult to reconcile with the normal metabolism in PET. In fact, this was unexpected because thalamic metabolism was reduced in an experimental model of chorea probably due to the reduced pallidothalamic afferents.10 Recently, experimental data11,12 revealed that the organization of basal ganglia is more complex than that of simple direct and indirect loops. The paradoxical effect of pallidotomy in dyskinesia13 and increased thalamic metabolism in choreic Huntington disease,14 which was the opposite of what would be expected from the traditional model, also clinically supported this complexity. As pointed out by Weeks et al,14 it is possible that generalized chorea with bilateral thalamic hyperperfusion in our patient may be related to the increased pallidothalamic activities instead of decreased activities.

A few pathologic studies of SC 15,16 have reported the presence of inflammatory lesions involving the striatum, thalamus, and cortex. It seems possible that the active inflammatory brain lesions are associated with focal hyperperfusion. Juhler and Paulson17 demonstrated that the areas of focal inflammation in the model of experimental allergic encephalomyelitis were associated with a focal increase of CBF. Also, there was ample SPECT evidence of regional hyperperfusion in various inflammatory diseases such as herpes encephalitis18 and toxoplasmosis.19 Thus, it is possible that the striatal and thalamic hyperperfusion in our SPECT 2 scan might represent the abnormally increased CBF that is related to the active inflammatory process in these structures, and chorea might be secondary to the striatothalamic neuronal dysfunction.

Another possibility for the discrepancies may be the heterogeneity in the pathomechanisms of chorea. Previous pathological investigations of patients with chorea did not identify any specific structural lesions common to the development of chorea,20 which suggested that the lesion responsible for the genesis of chorea might be located anywhere in the basal ganglia circuitry. Although the pathophysiological characteristics of the underlying disease are different, hyperperfusion in both the striatum and thalamus contralateral to the side of hemichorea was also reported in a patient with hyperglycemia.21 Therefore, it is likely that the functional imaging findings may be variable in different patients with chorea even in the cases of SC. Unfortunately, the number of cases of SC investigated by either SPECT or PET is still too limited to draw any firm conclusions. However, the unequivocal SPECT findings of striatothalamic hyperperfusion in our patient, contradictory to the previously normal SPECT results, clearly suggest that the variable perfusion patterns are seen in SC.

Back to top
Article Information

Accepted for publication July 14, 1998.

Reprints: Byung In Lee, MD, Professor of Neurology, Yonsei University College of Medicine, Severance Hospital, CPO Box 8044, Seoul, Korea.

Husby  Gvan de Rijn  IZabriskie  JBAbdin  ZHWilliams  RC Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;1441094- 1110Article
Bronze  MSDale  JB Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993;1512820- 2828
Weindl  AKuwert  TLeenders  KL  et al.  Increased striatal glucose consumption in Sydenham's chorea. Mov Disord. 1993;8437- 444Article
Goldman  SAmrom  DSzliwowski  HB  et al.  Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov Disord. 1993;8355- 358Article
Hill  AHerkes  GKRoche  P SPECT and MRI findings in Sydenham's chorea. J Neurol Neurosurg Psychiatry. 1994;57763Article
Heye  NJergas  MHotzinger  HFarahati  JPohlau  DPrzuntek  H Sydenham's chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol. 1993;240121- 123Article
Chang  LT A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25638- 643Article
Lee  JDKim  DIRyu  YHWhang  GJPark  CIKim  DG Technetium-99m-ECD brain SPECT in cerebral palsy: comparison with MRI. J Nucl Med. 1998;39619- 623
Roland  PEMeyer  EShibasaki  TYamamoto  YLThompson  CJ Regional cerebral blood flow changes in cortex and basal ganglia during voluntary movements in normal human volunteers. J Neurophysiol. 1982;48467- 480
Mitchell  IJJackson  ASambrook  MACrossman  AR The role of the subthalamic nucleus in experimental chorea: evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing study. Brain. 1989;1121533- 1548Article
Chesselet  MFDelfs  JM Basal ganglia and movement disorders: an update. Trends Neurosci. 1996;19417- 422Article
Parent  ACicchetti  F The current model of basal ganglia organization under scrutiny. Mov Disord. 1998;13199- 202Article
Suarez  JIMetman  LVReich  SGDougherty  PMHallett  MLenz  FA Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol. 1997;42807- 811Article
Weeks  RACeballos-Baumann  APiccini  PBoecker  HHarding  AEBrooks  DJ Cortical control of movement in Huntington's disease: a PET activation study. Brain. 1997;1201569- 1578Article
Colony  HSMalamud  N Sydenham's chorea: a clinicopathologic study. Neurology. 1956;6672- 676Article
Thiebaut  F Sydenham's chorea. Vinken  PJBruyn  GWeds.Handbook of Clinical Neurology. Amsterdam, the Netherlands North-Holland Publishing Co1968;409- 434
Juhler  MPaulson  OB Regional cerebral blood flow in acute experimental allergic encephalomyelitis. Brain Res. 1986;363272- 278Article
Schmidbauer  MPodreka  IWimberger  D  et al.  SPECT and MRI in herpes simplex encephalitis. J Comput Assist Tomogr. 1991;15811- 815Article
Catafau  AMSola  MLomena  FJGuelar  AMiro  JMSetoain  J Hyperperfusion and early Technetium-99m-HMPAO SPECT appearance of central nerve system toxoplasmosis. J Nucl Med. 1994;351041- 1043
Bruyn  GWPadberg  G Chorea and systemic lupus erythematosus: a critical review. Eur Neurol. 1984;23435- 448Article
Nabatame  HNakamura  KMatsuda  MFujimoto  NShio  H Hemichorea in hyperglycemia associated with increased blood flow in the contralateral striatum and thalamus. Intern Med. 1994;33472- 475Article